Neu H C, Chin N X, Labthavikul P
Antimicrob Agents Chemother. 1984 Jun;25(6):687-9. doi: 10.1128/AAC.25.6.687.
Coumermycin has been shown to inhibit Staphylococcus aureus and Staphylococcus epidermidis strains that are susceptible and those that are resistant to methicillin at concentrations less than or equal to 0.05 micrograms/ml. Listeria monocytogenes and Corynebacterium spp. resistant to cephalosporins were inhibited by less than or equal to 1.6 micrograms of coumermycin ml, and streptococcal species, with the exception of Streptococcus faecalis, were inhibited by 0.1 micrograms/ml. Cross-resistance with beta-lactams or aminoglycosides was not found. Coumermycin acted synergistically with ofloxacin, norfloxacin, and enoxacin against S. aureus but did not show synergy when combined with nafcillin, vancomycin, or rifampin. Coumermycin did not inhibit members of the family Enterobacteriaceae or Pseudomonas aeruginosa.
香豆霉素已被证明在浓度小于或等于0.05微克/毫升时,能抑制对甲氧西林敏感和耐药的金黄色葡萄球菌及表皮葡萄球菌菌株。对头孢菌素耐药的单核细胞增生李斯特菌和棒状杆菌属,在香豆霉素浓度小于或等于1.6微克/毫升时受到抑制,除粪肠球菌外的链球菌属在0.1微克/毫升时受到抑制。未发现与β-内酰胺类或氨基糖苷类有交叉耐药性。香豆霉素与氧氟沙星、诺氟沙星和依诺沙星对金黄色葡萄球菌有协同作用,但与萘夫西林、万古霉素或利福平联合使用时未显示协同作用。香豆霉素不抑制肠杆菌科成员或铜绿假单胞菌。